Small Pharma (AgeTech UK)

Psychedelics for depression.Forging a new path in pharmaceutical development by bridging the gap between academia and industry. With specific experience in IP and the drug development process, they integrate a robust IP strategy with the development plan required to guide close-to-clinic candidates through the clinical trials necessary to demonstrate proof-of-concept in patients....